Dragomir Dardanov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dragomir Dardanov has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Belli
Istituto Nazionale Tumori di Napoli, IRCCS “G. Pascale”, Via Mariano Semmola, 80131 Naples, Italy
2 shared publications - Dimitrios Schizas
First Department of Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, 11527 Athens, Greece
2 shared publications - Evgeni Zhivkov
Department of General and Hepato-Pancreatic Surgery, University Hospital "Alexandrovska" - Sofia; Medical University – Sofia, Bulgaria
2 shared publications - Giulia Turri
Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
2 shared publications - Jose Costa Maia
Department of Surgery, Hospital de São João, Porto Medical School, Porto, Portugal
2 shared publications - Kjetil Søreide
Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
2 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Elsevier in Surgical Oncology
- Vol. 69
International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot
- 26 October 2026
- Published by Elsevier in Surgical Oncology
- Vol. 69
Open AccessInternational survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot
- Open Access
- 6 October 2026
- Published by Pensoft Publishers in Journal of Biomedical and Clinical Research
- Vol. 19, 309-321
Low anterior resection syndrome: Risk factors, pathophysiology, assessment, and treatment – a narrative review
Aim: Low anterior resection syndrome (LARS) is a dysfunction of bowel evacuation following sphincter-preserving surgery (robotic, laparoscopic, or open) for rectal cancer. Patients commonly experience changes in bowel habits ranging from increased bowel frequency to faecal incontinence and evacuatory dysfunction. The aim of this study was to provide evidence-based recommendations for good clinical practice. Materials and methods: A literature search was conducted in PubMed and ResearchGate using the following keywords: low anterior resection syndrome, low anterior resection syndrome treatment, and low anterior resection syndrome scoring systems. Manual searches of references of the included studies were performed to identify other relevant publications. Only studies published in English were included. Results: In 2012 Emmertsen and Laurberg developed a questionnaire with a scoring system (the LARS score) that evaluates symptom severity and classifies patients into three groups: no LARS, minor LARS, and major LARS. A symptom-based therapeutic approach has been developed for the management of LARS. There is limited evidence that dietary modification improves symptoms. Medications such as loperamide and ramosetron have been shown to improve patients‘ quality of life. Pelvic floor rehabilitation is used to improve the function of the anal sphincter complex. Transanal irrigation has demonstrated significant improvement in symptoms. Sacral nerve modulation and posterior tibial nerve stimulation have shown promising results in patients with LARS who are resistant to conservative treatment. The creation of a colonic J-pouch has also been associated with a better quality of life compared with a straight coloanal or colorectal anastomosis. Conclusion: Many treatment modalities help relieve the symptoms of LARS; currently, however, no definitive cure exists. Further clinical research and studies are needed to develop effective treatment strategies and ultimately achieve a cure for LARS.
- 6 October 2026
- Published by Pensoft Publishers in Journal of Biomedical and Clinical Research
- Vol. 19, 309-321
Open AccessLow anterior resection syndrome: Risk factors, pathophysiology, assessment, and treatment – a narrative review
Aim: Low anterior resection syndrome (LARS) is a dysfunction of bowel evacuation following sphincter-preserving surgery (robotic, laparoscopic, or open) for rectal cancer. Patients commonly experience changes in bowel habits ranging from increased bowel frequency to faecal incontinence and evacuatory dysfunction. The aim of this study was to provide evidence-based recommendations for good clinical practice. Materials and methods: A literature search was conducted in PubMed and ResearchGate using the following keywords: low anterior resection syndrome, low anterior resection syndrome treatment, and low anterior resection syndrome scoring systems. Manual searches of references of the included studies were performed to identify other relevant publications. Only studies published in English were included. Results: In 2012 Emmertsen and Laurberg developed a questionnaire with a scoring system (the LARS score) that evaluates symptom severity and classifies patients into three groups: no LARS, minor LARS, and major LARS. A symptom-based therapeutic approach has been developed for the management of LARS. There is limited evidence that dietary modification improves symptoms. Medications such as loperamide and ramosetron have been shown to improve patients‘ quality of life. Pelvic floor rehabilitation is used to improve the function of the anal sphincter complex. Transanal irrigation has demonstrated significant improvement in symptoms. Sacral nerve modulation and posterior tibial nerve stimulation have shown promising results in patients with LARS who are resistant to conservative treatment. The creation of a colonic J-pouch has also been associated with a better quality of life compared with a straight coloanal or colorectal anastomosis. Conclusion: Many treatment modalities help relieve the symptoms of LARS; currently, however, no definitive cure exists. Further clinical research and studies are needed to develop effective treatment strategies and ultimately achieve a cure for LARS.
- Open Access
The Multipurpose Usage of Diffusion-Weighted MRI in Rectal Cancer
Background and Objectives: Colorectal cancer is the third most common oncological disease worldwide. The standard treatment of locally advanced rectal tumors is neoadjuvant radiochemotherapy in combination with surgical resection. The choice of specific treatment algorithm is highly dependent on MRI findings. The aim of this study is to show the potential role of ADC measurements in rectal cancer and their usage in different clinical scenarios. Materials and Methods: A total of 135 patients had rectal MRI evaluation. Seventy-five (56%) had histologically proven rectal adenocarcinoma and sixty (44%) were evaluated as rectal disease-free. An ADC measurement in the most prominent region of interest was obtained for all patients. Eighteen patients (24% of the rectal cancer group) had a second MRI after neoadjuvant chemoradiotherapy with comparison of the ADC values at the same region of interest as previously measured. Results: Rectal cancer ADC values were found to be significantly lower than the ones in the control group (p < 0.001). A statistically significant correlation was found when ADC values in rectal tumors of different T stages were compared (p = 0.039)—those with higher T stage as in locally advanced disease showed lower ADC values. Patients with extramural vascular invasion showed significantly lower ADC values (p = 0.01). There was a significant increase in ADC values after treatment (p < 0.001), and a negative correlation was observed (r = −0.6572; p = 0.004)—tumors with low initial ADC values showed a higher increase in ADC. Conclusions: ADC measurements have a complementary role in the assessment of rectal cancer and have the potential to predict the response to chemoradiotherapy and improve the planning of proper treatment strategies.
Open AccessThe Multipurpose Usage of Diffusion-Weighted MRI in Rectal Cancer
Background and Objectives: Colorectal cancer is the third most common oncological disease worldwide. The standard treatment of locally advanced rectal tumors is neoadjuvant radiochemotherapy in combination with surgical resection. The choice of specific treatment algorithm is highly dependent on MRI findings. The aim of this study is to show the potential role of ADC measurements in rectal cancer and their usage in different clinical scenarios. Materials and Methods: A total of 135 patients had rectal MRI evaluation. Seventy-five (56%) had histologically proven rectal adenocarcinoma and sixty (44%) were evaluated as rectal disease-free. An ADC measurement in the most prominent region of interest was obtained for all patients. Eighteen patients (24% of the rectal cancer group) had a second MRI after neoadjuvant chemoradiotherapy with comparison of the ADC values at the same region of interest as previously measured. Results: Rectal cancer ADC values were found to be significantly lower than the ones in the control group (p < 0.001). A statistically significant correlation was found when ADC values in rectal tumors of different T stages were compared (p = 0.039)—those with higher T stage as in locally advanced disease showed lower ADC values. Patients with extramural vascular invasion showed significantly lower ADC values (p = 0.01). There was a significant increase in ADC values after treatment (p < 0.001), and a negative correlation was observed (r = −0.6572; p = 0.004)—tumors with low initial ADC values showed a higher increase in ADC. Conclusions: ADC measurements have a complementary role in the assessment of rectal cancer and have the potential to predict the response to chemoradiotherapy and improve the planning of proper treatment strategies.
- Open Access
- 15 December 2022
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 33 (12) , 1004-1011
Perception of COVID-19 Pandemic Among IBD Clinicians and IBD Surgeons in Black Sea Region: A Cross-Sectional Questionnaire Study
Background: Since December 2019, the COVID-19 pandemic has created an increasing challenge in managing inflammatory bowel dis- ease patients both medically and surgically. Although several international and national medical/surgical associations published guide- lines in this area, there is still a huge difference between daily practices and these guidelines, especially depending on regional practices and governmental policies. Therefore, we aimed to investigate and define gastroenterologists’ and surgeons’ fear of COVID-19 and how they have managed inflammatory bowel disease patients during this pandemic in the Black Sea region. Methods: A 20-question survey was administered to 70 gastroenterology specialists and 80 general surgeons who are mainly focused on the management of inflammatory bowel disease in 5 countries in the Black Sea region. Results: The majority of respondents (81.3%) mentioned that they have concerns that their inflammatory bowel disease patients were at risk of contracting COVID-19. In addition, the majority of respondents (80.3%) believed that inflammatory bowel disease itself, inde- pendent of medications, might increase the risk of contracting COVID-19. The majority of gastroenterologists told that they did not stop inflammatory bowel disease medications due to the COVID-19 pandemic unless patients had COVID-19 disease. Surgeons overwhelm- ingly reached a consensus on how to test patients for COVID-19 perioperatively and came to a conclusion on which of the patients can- not wait to be operated. Both gastroenterologists and general surgeons, usually have similar perceptions. Conclusion: Despite the increasing number of definitive studies, it seems that there are still regional differences in the perception of COVID-19 and inflammatory bowel disease patient care during the pandemic. Cite this article as: Celasin H, Törüner M, Aghayeva S, et al. Perception of COVID-19 pandemic among IBD clinicians and IBD surgeons in Black Sea region: A cross-sectional questionnaire study. Turk J Gastroenterol. 2022;33(12):1004-1011.
- 15 December 2022
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 33 (12) , 1004-1011
Open AccessPerception of COVID-19 Pandemic Among IBD Clinicians and IBD Surgeons in Black Sea Region: A Cross-Sectional Questionnaire Study
Background: Since December 2019, the COVID-19 pandemic has created an increasing challenge in managing inflammatory bowel dis- ease patients both medically and surgically. Although several international and national medical/surgical associations published guide- lines in this area, there is still a huge difference between daily practices and these guidelines, especially depending on regional practices and governmental policies. Therefore, we aimed to investigate and define gastroenterologists’ and surgeons’ fear of COVID-19 and how they have managed inflammatory bowel disease patients during this pandemic in the Black Sea region. Methods: A 20-question survey was administered to 70 gastroenterology specialists and 80 general surgeons who are mainly focused on the management of inflammatory bowel disease in 5 countries in the Black Sea region. Results: The majority of respondents (81.3%) mentioned that they have concerns that their inflammatory bowel disease patients were at risk of contracting COVID-19. In addition, the majority of respondents (80.3%) believed that inflammatory bowel disease itself, inde- pendent of medications, might increase the risk of contracting COVID-19. The majority of gastroenterologists told that they did not stop inflammatory bowel disease medications due to the COVID-19 pandemic unless patients had COVID-19 disease. Surgeons overwhelm- ingly reached a consensus on how to test patients for COVID-19 perioperatively and came to a conclusion on which of the patients can- not wait to be operated. Both gastroenterologists and general surgeons, usually have similar perceptions. Conclusion: Despite the increasing number of definitive studies, it seems that there are still regional differences in the perception of COVID-19 and inflammatory bowel disease patient care during the pandemic. Cite this article as: Celasin H, Törüner M, Aghayeva S, et al. Perception of COVID-19 pandemic among IBD clinicians and IBD surgeons in Black Sea region: A cross-sectional questionnaire study. Turk J Gastroenterol. 2022;33(12):1004-1011.
- Open Access
- 1 September 2022
- Published by Bulgarian Surgical Society in ITEGAM-Journal of Engineering and Technology for Industrial Applications (ITEGAM-JETIA)
- Vol. 86 (3) , 107-115
Use of indocyanine green for liver function assessment and its role in predicting the risk of postoperative liver failure
Postoperative liver failure (POLF) is one of the most serious complications in abdominal surgery, as its appearance is often associated with an unfavorable outcome.OBJECTIVE: To investigate the role of Indocyanine Green (ICG) and Indocyanine Green Retention rate (ICG-R15) for assessment of liver function in order to predict the risk of POLF.MATERIAL AND METHODS: In 06.2021 – 11.2022, a prospective study was conducted, including 20 patients admitted in University Hospital "Alexandrovska" for malignant liver neoplasms. Liver function was assessed by static biochemical parameters and intravenous ICG administration (0.5 mg/kg), aiming to measure the residual blood concentration at the 15th minute (ICG-R15). The results and the probable correlation with clinico-morphological features were processed statistically.RESULTS AND DISCUSSION: The study included 13 men (65%) and 7 women (35%) with primary (5) and metastatic (15) liver tumors. 13 minor (15%, major liver interventions were not undertaken (p=0.001). In the ICG-R15 <15% group, regardless of major resection performed, POLF was not observed. The lack of significant deviations in static liver indicators with marked differences in ICGR15 clearly shows the need to combine methods for a precise liver function assessment. POLF was rapidly controlled due to consideration of the resection volume in context of ICG-R15.CONCLUSION: The ICG-R15 is an easy, safe, and valuable tool for assessing liver function and identifying patients at risk of POLF. Additional studies are needed, as the present study is initial for Bulgaria.
- 1 September 2022
- Published by Bulgarian Surgical Society in ITEGAM-Journal of Engineering and Technology for Industrial Applications (ITEGAM-JETIA)
- Vol. 86 (3) , 107-115
Open AccessUse of indocyanine green for liver function assessment and its role in predicting the risk of postoperative liver failure
Postoperative liver failure (POLF) is one of the most serious complications in abdominal surgery, as its appearance is often associated with an unfavorable outcome.OBJECTIVE: To investigate the role of Indocyanine Green (ICG) and Indocyanine Green Retention rate (ICG-R15) for assessment of liver function in order to predict the risk of POLF.MATERIAL AND METHODS: In 06.2021 – 11.2022, a prospective study was conducted, including 20 patients admitted in University Hospital "Alexandrovska" for malignant liver neoplasms. Liver function was assessed by static biochemical parameters and intravenous ICG administration (0.5 mg/kg), aiming to measure the residual blood concentration at the 15th minute (ICG-R15). The results and the probable correlation with clinico-morphological features were processed statistically.RESULTS AND DISCUSSION: The study included 13 men (65%) and 7 women (35%) with primary (5) and metastatic (15) liver tumors. 13 minor (15%, major liver interventions were not undertaken (p=0.001). In the ICG-R15 <15% group, regardless of major resection performed, POLF was not observed. The lack of significant deviations in static liver indicators with marked differences in ICGR15 clearly shows the need to combine methods for a precise liver function assessment. POLF was rapidly controlled due to consideration of the resection volume in context of ICG-R15.CONCLUSION: The ICG-R15 is an easy, safe, and valuable tool for assessing liver function and identifying patients at risk of POLF. Additional studies are needed, as the present study is initial for Bulgaria.
- Open Access
- 24 May 2022
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (7) , e1003-e1011
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
- 24 May 2022
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (7) , e1003-e1011
Open AccessEffects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
- 6 October 2007
- Vol. 12 (3) , 369-76
Investigation of circumferential resection margin in rectal cancer surgery.
Literature data suggest that investigation of the circumferential resection margin (CRM) in rectal cancer surgery gives significant information for prognosis of the disease and the quality of the performed operation. The aim of this study was to analyze the clinical and morphological aspects of CRM in pT3 tumors in relation to their significance for rectal cancer treatment and staging. Thirty patients with radically operated pT3 stage rectal cancer were investigated. The resected specimens were studied both macroscopically and microscopically to assess CRM and the quality of the performed operation. Six (20%) patients had positive CRM (CRM +; tumor cells in the margin or < 1 mm from it). These cases were characterized with deep infiltration (> 4 mm) in the rectal adventitia (perirectal tissue). Statistically significant correlation was found between CRM status and quality of the resected specimen (including the presence of rectal fascia in CRM). There was no correlation between pathological characteristics of the tumor and the status of CRM. The status of CRM is a factor independent from TNM classification. The presence of rectal fascia in CRM confirms the good quality of the operation. CRM+ could be a result of inadequate surgery or advanced disease. The status of CRM could be used in the decision-making for postoperative adjuvant treatment.
- 6 October 2007
- Vol. 12 (3) , 369-76
Investigation of circumferential resection margin in rectal cancer surgery.
Literature data suggest that investigation of the circumferential resection margin (CRM) in rectal cancer surgery gives significant information for prognosis of the disease and the quality of the performed operation. The aim of this study was to analyze the clinical and morphological aspects of CRM in pT3 tumors in relation to their significance for rectal cancer treatment and staging. Thirty patients with radically operated pT3 stage rectal cancer were investigated. The resected specimens were studied both macroscopically and microscopically to assess CRM and the quality of the performed operation. Six (20%) patients had positive CRM (CRM +; tumor cells in the margin or < 1 mm from it). These cases were characterized with deep infiltration (> 4 mm) in the rectal adventitia (perirectal tissue). Statistically significant correlation was found between CRM status and quality of the resected specimen (including the presence of rectal fascia in CRM). There was no correlation between pathological characteristics of the tumor and the status of CRM. The status of CRM is a factor independent from TNM classification. The presence of rectal fascia in CRM confirms the good quality of the operation. CRM+ could be a result of inadequate surgery or advanced disease. The status of CRM could be used in the decision-making for postoperative adjuvant treatment.
- 1 January 2006
- p. 31-4
[Pathologic handling and investigation of surgical resected specimen in rectal cancer].
A methodic for pathologic handling and investigation of surgical resection specimen in rectal cancer is presented. It is conformed with recent trends of multidisciplinary approach to rectal cancer. Surgeon is involved in macroscopic investigation of the fresh specimen, whether pathologist is responsible for macroscopic and histological examination of the fixed specimen. A model of clinicomorphologic reporting chart for rectal cancer is developed. Special attention is given to inspection for completeness of the "mesorectum" and rectal fascia, as well as investigation of circumferential resection margin. Precise and exact handling and investigation of resected specimen from rectal cancer patients improve the accuracy of the staging, serve valuable information for radicality and quality of the performed operation, and determine the appropriate adjuvant therapy.
- 1 January 2006
- p. 31-4
[Pathologic handling and investigation of surgical resected specimen in rectal cancer].
A methodic for pathologic handling and investigation of surgical resection specimen in rectal cancer is presented. It is conformed with recent trends of multidisciplinary approach to rectal cancer. Surgeon is involved in macroscopic investigation of the fresh specimen, whether pathologist is responsible for macroscopic and histological examination of the fixed specimen. A model of clinicomorphologic reporting chart for rectal cancer is developed. Special attention is given to inspection for completeness of the "mesorectum" and rectal fascia, as well as investigation of circumferential resection margin. Precise and exact handling and investigation of resected specimen from rectal cancer patients improve the accuracy of the staging, serve valuable information for radicality and quality of the performed operation, and determine the appropriate adjuvant therapy.
- 20 September 2005
- Published by Georg Thieme Verlag KG in Senologie - Zeitschrift für Mammadiagnostik und -therapie
- Vol. 2 (03) , A27
Evaluierung der retroareolaren Farbstoffinjektion bei der Sentinellymphknotenbiopsie durch Doppelfarbstoffmethode
Fur die klinische und wissenschaftliche Praxis würde es vom großen Interesse, wenn man eine Stelle in der Brust finden könnte, deren Lymphe unabhängig vom Sitz des Tumors zum Sentinellymphknoten abfliesst. Daher ist die retroareolare Region von besonderem Interesse, da wie es seit langer Zeit in der Literatur beschrieben wird, steht dieser Lymphbahnnetzwerk mit aller Lymphe der Brust in Zussamenhang. Ziel unserer Untersuchung ist den Lymphweg von der retroareolaren Region mit der Lymphbahn von der Tumorregion zu vergleichen und somit die Stelle der Sentinellumphknotenbiopsie durch die retroareolaren Farbstoffinjektion zu testen. Methode: Bei 43 Frauen mit Tumorsitz ausserhalb der Mamilla in c T1–2 N0 St. wurde retroareolar 2×0,7ml Patent Blue injektiert. Nach 6–8min wurden die SLNs mittels quer Inzision in der Axille gesucht. Ergebnisse: Es wurden bei 39 (90%) Frauen von 1 bis 3 SLNs gefunden. In 35 (80%) Fälle waren die Lymphknoten zweifarbig markiert. Nie wurden zwei verschiedene monofarbige (blaue oder grüne) Knoten gefunden. Zusammenfassung: Die Doppelfarbstoffmethode der retroareolaren und peritumoralen Farbstoffinjektion zeigt, dass beiden Regionen gleichen Lymhabfluss haben und dass die retroareolaren Injektion fur die Markierung der sentinellen Lymphknoten geeignet ist.
- 20 September 2005
- Published by Georg Thieme Verlag KG in Senologie - Zeitschrift für Mammadiagnostik und -therapie
- Vol. 2 (03) , A27
Evaluierung der retroareolaren Farbstoffinjektion bei der Sentinellymphknotenbiopsie durch Doppelfarbstoffmethode
Fur die klinische und wissenschaftliche Praxis würde es vom großen Interesse, wenn man eine Stelle in der Brust finden könnte, deren Lymphe unabhängig vom Sitz des Tumors zum Sentinellymphknoten abfliesst. Daher ist die retroareolare Region von besonderem Interesse, da wie es seit langer Zeit in der Literatur beschrieben wird, steht dieser Lymphbahnnetzwerk mit aller Lymphe der Brust in Zussamenhang. Ziel unserer Untersuchung ist den Lymphweg von der retroareolaren Region mit der Lymphbahn von der Tumorregion zu vergleichen und somit die Stelle der Sentinellumphknotenbiopsie durch die retroareolaren Farbstoffinjektion zu testen. Methode: Bei 43 Frauen mit Tumorsitz ausserhalb der Mamilla in c T1–2 N0 St. wurde retroareolar 2×0,7ml Patent Blue injektiert. Nach 6–8min wurden die SLNs mittels quer Inzision in der Axille gesucht. Ergebnisse: Es wurden bei 39 (90%) Frauen von 1 bis 3 SLNs gefunden. In 35 (80%) Fälle waren die Lymphknoten zweifarbig markiert. Nie wurden zwei verschiedene monofarbige (blaue oder grüne) Knoten gefunden. Zusammenfassung: Die Doppelfarbstoffmethode der retroareolaren und peritumoralen Farbstoffinjektion zeigt, dass beiden Regionen gleichen Lymhabfluss haben und dass die retroareolaren Injektion fur die Markierung der sentinellen Lymphknoten geeignet ist.